Spheroid formation. All experiments were performed using spheroids. For spheroid generation, HCT-116, HT-29 and HCT-15 cells were harvested from culture flasks by trypsinization, resuspended in their respective supplemented medium and seeded in ultra-low attachment round-bottom 96-well plates (Nunclon Sphera TM , Thermo Fisher Scientific) at a density of 10.000 viable cells per well. Plates were incubated at 37 °C with 5% CO2 for 96 hours to allow spheroid formation and then used for the experiments.
Compounds. All compounds: KP1339, oxaliplatin and cisplatin were synthesized at the Institute of Inorganic Chemistry, University of Vienna, as described previously 26, 46, 47 .
Alamar Blue Test. KP1339 was first dissolved in DMSO, and stock solutions were prepared in the appropriate medium according to the cell line and diluted stepwise to obtain a serial dilution. 100 µl of the respective dilutions were added to each well, and the plates were incubated for 96 hours at 37 °C with 5% CO2. A 440 µM resazurin sodium salt (Sigma-Aldrich, Austria) in PBS solution was prepared and 20 µl were added to each well. The plates were incubated for 16 hours at 37 °C with 5% CO2. Fluorescence was measured with a Synergy HT reader (BioTek).
Treatment.
For testing the ability of KP1339 to induce ICD in vitro, 3D tumor spheroids were first treated with the compounds as follows: KP1339 (100 µM), oxaliplatin (20 µM) and cisplatin (20 µM) were used as positive and negative controls, respectively. Spheroids were incubated with the compounds for 24 hours at 37 °C with 5% CO2 and then processed for further experiments. All the concentrations were carefully selected based on the IC50 values obtained by the Alamar Blue test. The IC50 values after 96 h of drug exposure were selected for performing the experiments.
Flow Cytometry Analysis. After treatment, spheroids were collected and pooled. Samples were washed with PBS followed by dissociation with Tryple Express (Gibco, Austria) for 15 minutes at 37 °C. 500 µl medium containing 10% FCS were added to each tube to stop trypsinization. Samples were centrifuged at 2200 g for 3 minutes and resuspended in ice cold FACS buffer containing the primary antibody: Calreticulin (#ab2907 Abcam, United Kingdom) and incubated for 30 minutes at 4 °C. Samples were washed twice and resuspended in FACS buffer containing the secondary antibody Goat Anti Rabbit Alexa Fluor 488 (# ab150077Abcam, United Kingdom) and incubated at 4 °C for 20 minutes. Samples were washed twice, resuspended in FACS buffer containing propidium iodide and transferred into 96-well plates for measurements. Samples were measured immediately by using a
